Test Dentifrice

Preclinical

HHALEON

Test Dentifrice is one of 2 therapeutic programs targeting Dental Plaque. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

Dental PlaqueCompleted

Dental PlaquePreclinical

Completed

Competition

Competitive Landscape

2 competitors in Dental Plaque

#DrugCompanyPhaseTrials

Colgate Cavity Protection

GSK

Preclinical

1 2

Test Dentifrice

HHALEON

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

PreclinicalRecruiting

Dental Plaque

NCT07704905

Clinical

Trials by Indication[1]

Dental Plaque2 trials

An 8-Week Randomized, Controlled, Examiner-Blind, Clinical Study Investigating the Efficacy of an Experimental Dentifrice Containing Stannous Fluoride in Improving Gingival Health

Recruiting·HHALEON·Preclinical·NCT07704905·110 enrolled

A 24-Week, Randomised, Controlled, Examiner-blind, Clinical Study to Evaluate the Efficacy of an Experimental Stannous Fluoride Dentifrice in Improving Gingival Health and Reducing Plaque Accumulation

Completed·HHALEON·Preclinical·NCT07255040·284 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Test Dentifrice. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Test Dentifrice. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — HALEON company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: HHALEON

Test Dentifrice

Status by Indication[2][1]

Competitive Landscape

Expected Milestones

Q4 2026

Trials by Indication[1]

Dental Plaque2 trials

References

Drug Info

Quick Facts

Related News